☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
US FDA’s Approval
QBiotics' Stelfonta (tigilanol tiglate) Receives the US FDA's Approval as the First Treatment for Non-Metastatic MCT in Dogs
November 17, 2020
CSL Behring's Haegarda (C1 Esterase Inhibitor) Receives the US FDA's Approval for Pediatric Patients with Hereditary Angioedema
September 29, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.